Vedolizumab
TAK01769
Approved mab active
Quick answer
Vedolizumab for Moderately to Severely Active Crohn's Disease is a Approved program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Moderately to Severely Active Crohn's Disease
- Phase
- Approved
- Modality
- mab
- Status
- active